PATH-09. SJMB12 CLINICAL TRIAL: DISCREPANCY BETWEEN LOCAL AND CENTRAL PATHOLOGY IN ASSESSING ANAPLASTIC MEDULLOBLASTOMA – REPORT FROM A SINGLE SITE EXPERIENCE

INTRODUCTION: SJMB12 is a phase 2 clinical trial led by the St. Jude Children’s Research Hospital (St. Jude) that enrolls patients with medulloblastoma based on their biological subgroup. The large cell/anaplastic (LCA) histologic variant has been identified as an important independent risk factor a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Khuong-Quang, Dong-Anh, Williamson, Karli, MacGregor, Duncan, Orr, Brent A, Gajjar, Amar, Robinson, Giles W, Sullivan, Michael J, Hansford, Jordan R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Pathology and Molecular Diagnosis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715382/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.645
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia